Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection.
In the absence of specific antibody, opsonization of Streptococcus pneumoniae may be mediated by the alternative complement pathway (AP) or by C-reactive protein (CRP) via C1 binding. To determine the role of these mechanisms in pneumococcal (PNC) disease, we studied 19 patients with differing severities of PNC infection. C4 and CRP levels and zymosan-induced consumption of 50% hemolytic complement (CH50) were measured in specimens obtained acutely and then weekly. In patients with complicated illness, the modified mean CH50 in acute sera was 178 +/- 57 U/ml, significantly lower than the mean CH50 of 331 +/- 80 U/ml in patients with uncomplicated illness (P less than 0.05). The values of the two groups on a given day approximated each other on days 7, 14, and 23. Consumption of complement by zymosan was also lower in acute sera of patients with complicated illness, with a mean value of 19 +/- 18 U/ml compared with 58 +/- 30 U/ml in those with uncomplicated illness (P less than 0.05). This difference was also seen on day 7 (P less than 0.05). Disease involving lower-numbered PNC serotypes (less than 10) correlated with reduced availability of AP factors in acute sera, independent of illness severity. Mean CRP levels were inversely related to zymosan-induced complement activation in patients with complicated illness. These data suggest that in vivo depletion of AP factors is significantly greater in patients with complicated illness and is associated with high CRP levels. CRP may enhance AP activation via C3 convertase generation and function with it as a preantibody host defense mechanism.
R A
RA
Rabinovitch
S M
SM
Koethe
J H
JH
Kalbfleisch
L C
LC
Preheim
M W
MW
Rytel
D000328:Adult; D000368:Aged; D002097:C-Reactive Protein / Q000032:analysis*; D003167:Complement Activation; D003181:Complement C4 / Q000032:analysis; D003170:Complement Pathway, Alternative; D005260:Female; D006801:Humans; D008297:Male; D008586:Meningitis, Pneumococcal / Q000276:immunology*; D008875:Middle Aged; D010033:Otitis Media / Q000209:etiology / Q000276:immunology; D011008:Pneumococcal Infections / Q000276:immunology*; D011018:Pneumonia, Pneumococcal / Q000276:immunology*; D018805:Sepsis / Q000276:immunology; D015054:Zymosan / Q000494:pharmacology
D003181:Complement C4; D002097:C-Reactive Protein; D015054:Zymosan